Legal Representation
Attorney
Julianne Abelman
USPTO Deadlines
Next Deadline
733 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-08-08)
Due Date
August 08, 2027
Grace Period Ends
February 08, 2028
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 21, 2023 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Nov 21, 2023 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Nov 21, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Aug 8, 2023 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Aug 8, 2022 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Aug 8, 2017 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 5, 2017 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| May 24, 2017 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Apr 25, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 25, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 5, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 7, 2017 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 7, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 7, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 7, 2017 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 7, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 1, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 1, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 26, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific research within the medical, pharmaceutical and bacteriological area; providing scientific consultancy and information in relation to the aforementioned scientific research; testing of pharmaceuticals; packaging design, designing and development of medical equipment; developing pharmaceutical and medical preparations; design and development of pharmaceutical formulations; design and development of granulation technology and tablet technology; providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
First Use Anywhere:
20091200
First Use in Commerce:
20091200
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"